Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autoimmune Haemolytic Anaemia”

137 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 137 results

Not applicableLooking for participantsNCT06539169
What this trial is testing

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Who this might be right for
Alpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more
xCures 1,000
Early research (Phase 1)Not Yet RecruitingNCT07287930
What this trial is testing

YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 13
Not applicableLooking for participantsNCT05937828
What this trial is testing

OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia

Who this might be right for
Immune ThrombocytopeniaAutoimmune Hemolytic AnemiaEvans Syndrome
University Hospital, Bordeaux 3,500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07453368
What this trial is testing

Orelabrutinib in the Treatment of Relapsed/Refractory AIHA

Who this might be right for
Autoimmune Hemolytic Anemia (AIHA)
Peking Union Medical College Hospital 50
Early research (Phase 1)Active Not RecruitingNCT06231368
What this trial is testing

CNCT19 for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy.

Who this might be right for
Autoimmune Hemolytic AnemiaAutologous CD19 CAR-TFailure of Three or More Lines of Therapy
Institute of Hematology & Blood Diseases Hospital, China 6
Large-scale testing (Phase 3)Study completedNCT03347396
What this trial is testing

Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion (Cardinal Study)

Who this might be right for
Agglutinin Disease, Cold
Bioverativ, a Sanofi company 24
Large-scale testing (Phase 3)UnknownNCT05057481
What this trial is testing

Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus

Who this might be right for
Autoimmune Hemolytic AnemiaSystemic Lupus Erythematosus
Assiut University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07104565
What this trial is testing

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

Who this might be right for
Immune Thrombocytopenia
Incyte Corporation 56
Not applicableUnknownNCT05711264
What this trial is testing

Presence of Circulating Cluster of Differentiation 4 Positive 28 Null T Helper Lymphocytes(CD4+CD28-) in Patients With Autoimmune Hemolytic Anemia.

Who this might be right for
Autoimmune Hemolytic Anemia
Assiut University 46
Large-scale testing (Phase 3)WithdrawnNCT01206907
What this trial is testing

Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects

Who this might be right for
Chronic Pain
Endo USA Inc., a Keenova Therapeutics Company
Very early researchLooking for participantsNCT07205315
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia (B-ALL)Chronic Lymphocytic Leukemia (CLL)B-cell Non-Hodgkin's Lymphoma (B-NHL)+1 more
Grit Biotechnology 28
Large-scale testing (Phase 3)Active Not RecruitingNCT05648968
What this trial is testing

Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Novartis Pharmaceuticals 90
Testing effectiveness (Phase 2)Ended earlyNCT04661033
What this trial is testing

Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Sanofi 8
Not applicableNot Yet RecruitingNCT07149818
What this trial is testing

A Single-arm Phase 2 Prospective Clinical Study of Linprixel in the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
Peking Union Medical College Hospital 22
Testing effectiveness (Phase 2)UnknownNCT03944447
What this trial is testing

Outcomes Mandate National Integration With Cannabis as Medicine

Who this might be right for
Chronic PainChronic Pain SyndromeChronic Pain Due to Injury+30 more
OMNI Medical Services, LLC 200,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05757570
What this trial is testing

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

Who this might be right for
Immune ThrombocytopeniaIdiopathic Thrombocytopenic PurpuraWarm Autoimmune Hemolytic Anemia+1 more
Alpine Immune Sciences, Inc. 30
Early research (Phase 1)Study completedNCT07075484
What this trial is testing

YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
China Immunotech (Beijing) Biotechnology Co., Ltd. 7
Testing effectiveness (Phase 2)Ended earlyNCT03075878
What this trial is testing

A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Alexion Pharmaceuticals, Inc. 8
Large-scale testing (Phase 3)Study completedNCT05132127
What this trial is testing

Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in Japan

Who this might be right for
Cold Agglutinin Disease
Sanofi 7
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Load More Results